CD1-MR1 2015* , ,
Presentations this author is a contributor to:
CD62L+ NKT cells have superior in vivo persistence and anti-tumor activity (#149)
4:00 PM
Leonid Metelitsa
Poster Listing
Reciprocal inhibition of NKT cells and tumor-associated macrophages in the tumor microenvironment (#79)
11:20 AM
Amy N Courtney
Session 11 - Autoimmunity/Cancer II